NCT04739384View on ClinicalTrials.gov

Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

June 20, 2022

Study Completion Date

June 20, 2022

Conditions
Acute Coronary SyndromeSTEMINSTEMICoronary Artery DiseaseMyocardial Infarction
Interventions
DRUG

Ticagrelor 90mg

Ticagrelor 90 mg followed by Ticagrelor 60 mg

DRUG

Ticagrelor 60 mg

Ticagrelor 60 mg followed by Ticagrelor 90 mg

Trial Locations (1)

80131

Professor Giovanni Esposito, Naples

Sponsors

Collaborators (1)

AdvicePharma Group
All Listed Sponsors
collaborator

AdvicePharma Group

UNKNOWN

lead

Federico II University

OTHER